🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06944834
Starting soon Not applicable

A Study on the Safety and Functionality of the Implantable Wireless Brain-Computer Interfaces for Motor Rehabilitation

NCT06944834 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai StairMed Technology Co., Ltd.
Phase
Not applicable
Started
2025-04
Last updated
2025-04-25

Condition(s) studied

QuadriplegiaAmputationsSpinal Cord Injuries (SCI)Brainstem Stroke

Investigational drug(s) / intervention(s)

Implant

Implant: Implantation of the device and follow-up

Study summary

The objective of this study is to evaluate the safety and efficacy of minimally invasive, wireless brain-machine interface system (WRS) in patients with paralysis (resulting from spinal cord injuries, brainstem strokes, amyotrophic lateral sclerosis, or other motor neuron diseases causing complete or incomplete quadriplegia) or bilateral upper limb amputations. By leveraging brain-machine interface alternative technology, participants can use brain signals to control external devices (such as moving cursors, wheelchairs, robotic arms, WeChat Mini Programs, and other physical assistive devices), thereby improving their motor function and quality of life.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18-65 years; * Patients with complete or incomplete quadriplegia due to spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis (ALS), or other motor neuron diseases, or those with bilateral upper limb amputations; * Normal motor cortex function confirmed by neurological assessment; * Muscle strength of bilateral or unilateral upper limbs ≤ Grade 3; * Patients who have received standardized treatment and met diagnostic criteria for at least 12 months before screening, with stable disease status for ≥6 months; * Expected lifespan ≥12 months; * Normal cognitive function; * Normal hearing and vision, or corrected vision to normal with standard lenses; * Patients with stable caregivers; * Willing to sign informed consent and able to comply with follow-up requirements. Exclusion Criteria: * Patients with neuropsychiatric disorders or psychological impairments; * Patients with brain MRI findings showing hemorrhage, tumors, anatomical abnormalities, or distortions; * History of severe systemic diseases (e.g., cardiac, pulmonary, hepatic, renal, thyroid, gastrointestinal, or hematologic disorders), poorly controlled diabetes, or pregnancy in females; * History of infectious diseases (e.g., syphilis, HIV), severe traumatic brain injury, or major surgeries; * Presence of metal implants or devices (e.g., cochlear implants, pacemakers, neurostimulators, defibrillators), except for dental implants or other implants deemed non-interfering; * Surgical or anesthesia contraindications as determined by surgeons or anesthesiologists; * Morbid obesity (BMI \>40); * Hearing impairment or uncorrectable visual deficits that would hinder prolonged computer monitor viewing; * Current participation in other clinical trials; * Other conditions considered unsuitable by investigators or medical staff.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Second Affiliated Hospital of Air Force Medical University Xi'an Shaanxi

More Shanghai StairMed Technology Co., Ltd. trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06944834 on ClinicalTrials.gov ↗ ← All trials in China